Viking Global Investors

← Back to your selection

All recorded activity

Rounds participated in: 3
Confirmed lead rounds: —
New companies: 3
Funding in participating rounds: $309.5M

By stage

Series B1

Series C+1

Undisclosed1

By primary sector

Healthtech2

Biotech1

By country

United States3

Rounds

3 in all activity

Jul 8

Pearl Health

Provides an AI platform for healthcare providers to manage risk and improve care for Medicare patients

$110MEquity+Debt

Role not disclosed

Jun 9

GT Medical Technologies

Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors

$100MSeries E

Role not disclosed

Jun 8

City Therapeutics

Develops next-generation RNAi therapeutics and engineering platform for multiple disease areas

$99.5MSeries B

Role not disclosed

← Back to your selection

All recorded activity

Rounds participated in: 3
Confirmed lead rounds: —
New companies: 3
Funding in participating rounds: $309.5M

By stage

Series B1

Series C+1

Undisclosed1

By primary sector

Healthtech2

Biotech1

By country

United States3

Rounds

3 in all activity

Jul 8

Pearl Health

Provides an AI platform for healthcare providers to manage risk and improve care for Medicare patients

$110MEquity+Debt

Role not disclosed

Jun 9

GT Medical Technologies

Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors

$100MSeries E

Role not disclosed

Jun 8

City Therapeutics

Develops next-generation RNAi therapeutics and engineering platform for multiple disease areas

$99.5MSeries B

Role not disclosed